Spectral Precise Image Study for Brain Tumors

ConditionBrain Tumors
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorPhilips Clinical & Medical Affairs Global

About this trial

The goal of this observational study is to explore the image quality of spectral CT deep learning reconstruction technology (Spectral Precise Image) of patients with confirmed brain tumors.

The main question it aims to answer is:

The Image Quality (IQ) and diagnostic confidence of Spectral Precise Image reconstructions

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Patients with clinical and radiology (MRI/CT) diagnosed brain tumors.

Patients who underwent contrast enhanced scans using the Spectral CT 7500.

Study participants with age ≥ 18 years old.

Study participants that have signed Informed Consent Form (ICF)

Disqualifiers

The clinical data or radiological information is considered incomplete after evaluation by the investigator.

Study participant that was enrolled in this study in the past

Data from study participants deemed unsuitable for enrollment based on the investigator's evaluation

Trial population

The study population from Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Trial design

Design model

Case-only

Time perspective

Other

Treatments tested in this trial

  • This is an observational data collection study

    Device

    This is an observational data collection study

Treatment groups

No treatment groups listed

Trial outcomes

Primary outcomes

1

Subjective Image quality using Likert score (1-5)

Image quality will be assessed by 2 radiologists using Likert score on a scale ranging from 1(poor) to 5(Excellent)

Time frame
From date of image reconstruction until the date of image reading completion, anticipated 3Months.
2

Objective Image Quality

The objective quality of the image is evaluated by measuring the CT value shown in the image.

Time frame
From date of image reconstruction until the date of image reading completion, anticipated 3Months.

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Philips Clinical & Medical Affairs Global

Lead sponsor

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Collaborator